Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greice M Zickuhr

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Analytical and Bioanalytical Chemistry|May 23, 2024
DESI-MSI-guided exploration of metabolic-phenotypic relationships reveals a correlation between PI 38:3 and proliferating cells in clear cell renal cell carcinoma via single-section co-registration of multimodal imagingGreice M Zickuhr, In Hwa Um, Alexander Laird, et al.
Biochemistry|January 30, 2025
Kinetic and Thermodynamic Characterization of Human 4-Oxo-l-proline Reductase CatalysisEnnio Pečaver, Greice M Zickuhr, Teresa F G Machado, et al.
Npj Imaging|September 16, 2025
Kidney tumoroid characterisation by spatial mass spectrometry with same-section multiplex immunofluorescence uncovers tumour microenvironment lipid signatures associated with aggressive tumour phenotypesHazem Abdullah, Greice M Zickuhr, In Hwa Um, et al.
Biochemistry|August 15, 2023
Human 2'-Deoxynucleoside 5'-Phosphate <i>N</i>-Hydrolase 1: Mechanism of 2'-Deoxyuridine 5'-Monophosphate HydrolysisSuneeta Devi, Anna E Carberry, Greice M Zickuhr, et al.
Translational Oncology|September 19, 2024
Defining the mode of action of cisplatin combined with NUC-1031, a phosphoramidate modification of gemcitabineDillum Patel, Alison L Dickson, Greice M Zickuhr, et al.
ACS Chemical Biology|October 18, 2025
Improved Nucleoside (2'-Deoxy)Ribosyltransferases Maximize Enzyme Promiscuity while Maintaining Catalytic EfficiencyPeijun Tang, Greice M Zickuhr, Alison L Dickson, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2023
The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agentJennifer Bré, Alison L Dickson, Oliver J Read, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Analytical and Bioanalytical Chemistry|May 23, 2024
DESI-MSI-guided exploration of metabolic-phenotypic relationships reveals a correlation between PI 38:3 and proliferating cells in clear cell renal cell carcinoma via single-section co-registration of multimodal imagingGreice M Zickuhr, In Hwa Um, Alexander Laird, et al.
Biochemistry|January 30, 2025
Kinetic and Thermodynamic Characterization of Human 4-Oxo-l-proline Reductase CatalysisEnnio Pečaver, Greice M Zickuhr, Teresa F G Machado, et al.
Npj Imaging|September 16, 2025
Kidney tumoroid characterisation by spatial mass spectrometry with same-section multiplex immunofluorescence uncovers tumour microenvironment lipid signatures associated with aggressive tumour phenotypesHazem Abdullah, Greice M Zickuhr, In Hwa Um, et al.
Biochemistry|August 15, 2023
Human 2'-Deoxynucleoside 5'-Phosphate <i>N</i>-Hydrolase 1: Mechanism of 2'-Deoxyuridine 5'-Monophosphate HydrolysisSuneeta Devi, Anna E Carberry, Greice M Zickuhr, et al.
Translational Oncology|September 19, 2024
Defining the mode of action of cisplatin combined with NUC-1031, a phosphoramidate modification of gemcitabineDillum Patel, Alison L Dickson, Greice M Zickuhr, et al.
ACS Chemical Biology|October 18, 2025
Improved Nucleoside (2'-Deoxy)Ribosyltransferases Maximize Enzyme Promiscuity while Maintaining Catalytic EfficiencyPeijun Tang, Greice M Zickuhr, Alison L Dickson, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2023
The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agentJennifer Bré, Alison L Dickson, Oliver J Read, et al.
Pageof 1